Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration

Urology

Volumn 47, Issue 5, 1996, Pages 693-698

  Alexander, Erik E ^a   Qian, Junqi ^a   Wollan, Peter C ^a   Myers, Robert P ^a   Bostwick, David G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE TUMOR; PROSTATECTOMY;

EID: 0029944174     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00004-0     Document Type: Article

References (26)

1. McNeal JE, and Bostwick DG: Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 17: 64-71, 1986.
2. Bostwick DG, and Brawer MK: Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 59: 788-794, 1987.
3. Bostwick DG: High grade prostatic intraepithelial neoplasia: the most likely precursor of prostate cancer. Cancer 75: 1823-1836, 1995.
4. Troncoso P, Babaian RJ, Ro JY, Grignon DJ, von Eschenbach AC, and Ayala AG: Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. Urology 34(suppl): 52-56, 1989.
5. Drago JR, Mostofi FK, and Lee F: Introductory remarks and workshop summary. Urology 34(suppl): 2-3, 1989.
6. Keetch DW, Humphrey P, Stahl D, Smith DS, and Catalona WJ: Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol 154: 347-351, 1995.
7. Weinstein MH, and Epstein JI: Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol 24: 624-629, 1993.
8. Davidson D, Bostwick DG, Qian J, Wollan PC, Oesterling JE, Rudders RA, Siroky M, and Stilmant M: Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol 154: 1295-1299, 1995.
9. Brawer MK, Bigler SA, Sohlberg OE, Nagle RB, and Lange PH: Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology 38: 103-107, 1991.
10. Bostwick DG, Qian J, and Frankel K: The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol 154: 1791-1794, 1995.
11. Richie JP, Kavoussi LR, Ho GT, Vickers MA, O'Donnell MA, St Laurent D, Chen A, Goldstein DS, and Loughlin KR: Prostate cancer screening: role of digital rectal examination and prostatic-specific antigen. Ann Surg Oncol 1: 117-120, 1994.
12. Brawer MK, Rennels MA, Nagle RB, Schifman R, and Gaines JA: Serum prostate specific antigen and prostate pathology in men having simple prostatectomy. Am J Clin Pathol 92: 760-764, 1989.
13. Brawer MK: Prostatic intraepithelial neoplasia and prostate-specific antigen. Urology 34 (suppl 6): 62-65, 1989.
14. Ronnett BM, Carmichael MJ, Carter HB, and Epstein JI: Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels. J Urol 150: 386-389, 1993.
15. Blackwell KL, Bostwick DG, Myers RP, Zincke H, and Oesterling JE: Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. J Urol 151: 1565-1570, 1994.
16. Qian J, Wollan P, and Bostwick DG: The extent and multicentricity of high grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol (in press).
17. Vessella RL, Noteboom J, and Lange PH: Evaluation of the Abbott IMx® automated immunoassay of prostate-specific antigen. Clin Chem 38: 2044-2054, 1992.
18. Bostwick DG, Myers RP, and Oesterling JE: The staging of prostate cancer. Semin Surg Oncol 10: 60-72, 1994.
19. Littrup PJ, William CR, Egglin TK, and Kane RA: Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques. Radiology 179: 49-53, 1991.
20. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, and Cooner WH: Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147: 815-816, 1992.
21. Humphrey PA, and Vollmer RT: Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol 21: 799-804, 1990.
22. Lee F, Torp-Pedersen ST, Carroll JT, Siders DB, Christensen-Day C, and Mitchell AE: Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia. Urology 34(suppl 6): 4-8, 1989.
23. McNeal JE, Alroy J, Leav I, Redwine EA, Freiha FS, and Stamey TA: Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. Am J Clin Pathol 90: 23-32, 1988.
24. Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, and Yang N: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 141: 1076-1083, 1989.
25. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, and Walsh PC: Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume, and benign hyperplasia. J Urol 143: 747-752, 1990.
26. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, and Ratliff TL: Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 154: 407-413, 1995.